Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The research study is being conducted to test how two different types of Positron Emission
Tomography (PET/CT) scans could be used to image a type of heart disorder called amyloidosis
(AL). There will be two groups in the study. One group will have PET/CT scans using an
imaging drug called 18F-NOS and the other group will have PET/CT scans using a drug called
Florbetaben. subject will be assigned to one of the groups when she/he agrees to be in the
study.